[1] Zhang S, et al. SKLB12, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo. Clin Cancer Res. 211, 17(13), 4439-445.
[2] Nie W, et al. Synergic antitumor effect of SKLB12 and local hyperthermia in 4T1 and CT26. 212. Doi 1.17/s1238-12-225-2.